Acquisition (code A) of 5,020 shares at $0 per share.
Reporting Person ABERNETHY MATT · Officer Title Chief Financial Officer · Transaction Code A
Traded Sep 11, 2026 · Disclosed Sep 15, 2026
Source: SEC Form 4 · 0001724097-26-000010 · filed 2026-09-15 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "NEUROCRINE BIOSCIENCES INC (NBIX)." Disclosed 2026-09-15. https://desqlong.com/cards/0001724097-26-000010-1 (retrieved 2026-09-26).